ExaCare AI Raises $30M Series A to Reimagine Admissions and Launch a Powerful Suite of AI Agents for Skilled Nursing & Home Care

Insight Partners-led funding will accelerate ExaCare AI's development of intelligent decisioning, clinical insight, reimbursement automation, and go-to-market expansion; ExaCare AI also announces five new advisors to guide product roadmap.

NEW YORK, Oct. 16, 2025 /PRNewswire/ -- ExaCare AI, a trailblazer in automation for operations teams in post-acute care facilities, today announced a $30 million Series A round led by global software investor Insight Partners, with participation from Foundation Capital, Bienville Capital, and select post-acute operators. The new capital will scale ExaCare's AI platform for skilled nursing facilities and expand product, engineering, and customer support. ExaCare AI powers 1500+ facilities, including customers such as National Healthcare Associates, Journey Healthcare, Ignite Medical Resorts, Monarch Healthcare Management, and Majestic Care.

Across post-acute care, admissions teams are under pressure to make life-changing decisions in minutes often with incomplete information. Referral packets arrive as vast, unstructured documents, leading to clinical deal breakers getting buried, slow and inconsistent communication with referral sources, increased wait times for patients and families, operator revenue loss, and staff burnout. ExaCare AI exists to change this reality.

ExaCare AI enables skilled nursing facilities to make decisions faster and with greater confidence the moment a referral arrives. The platform ingests unstructured packets, surfaces clinical deal breakers, highlights risk and readiness signals, standardizes criteria across teams and shifts, and streamlines communication to reduce back and forth. The goal is safe, confident placements with less administrative burden.

"Our vision is to build an AI operating system for all of post-acute," said Laird Russell, Co-founder and CEO of ExaCare AI. "Powerful AI agents will work alongside every team to turn scattered data into clear next steps. When every decision is auditable, every handoff is complete, and every workflow adapts in real time, caregivers can focus entirely on people and outcomes. I spent three and a half years with a brain injury in and out of medical care. Creating this new world is personal for me, and it is why we are investing deeply in proprietary models that are purpose built for this setting."

"Post-acute providers operate under razor-thin margins and chronic staffing shortages, which have a real impact on health outcomes," said George Mathew, Managing Director at Insight Partners. "ExaCare's agentic AI platform is addressing this head-on by making admissions simpler, more reliable, and measurably faster for operators and the people they serve. Laird and the ExaCare AI team are relentless in their mission to improve post-acute care, and we're thrilled to back them on their journey."

In addition to the Series A, ExaCare is also announcing five new advisors who will help guide the company's product roadmap with deep domain expertise, working hand-in-hand with ExaCare to build a custom-fit platform with features that matter the most to clinicians, caregivers, and administrators. ExaCare is pleased to welcome:

• Ephram Ostreicher, Chief Operating Officer at National Healthcare Associates
• Bernie McGuinness, President and CEO at Journey
• Austin Steele, Chief Strategy Officer at Journey
• Tim Fields, Co-founder and CEO at Ignite Medical Resorts
• Renee Pruzansky, Vice President of Strategy and Business Development at Infinite Care

Introducing ExaCare AI Agents: A New Workforce for Skilled Nursing

ExaCare AI is building a breakthrough AI model purpose-built for post-acute care. It understands referral packets, payer rules, care histories, and the clinical signals that matter most during admission, allowing facilities to move from reactive processes to proactive, data-driven operations grounded in real-time insight. This foundation will power a suite of AI agents that work alongside care teams to streamline decisions and documentation, creating a connected system that reduces paperwork, improves consistency, and gives staff more time for patient care.

Each agent focuses on a specific part of the workflow:

• Admissions Agent: Triage referral packets, extract critical clinical information, align to facility criteria, and recommend disposition with clear rationales and audit trails.
• Reimbursement Agent: Guide documentation and coding for accurate, timely reimbursement across Medicare, Medicaid, and managed care. Reduce denials with proactive validation, completeness checks, and evidence collection.
• Clinical Agent: Surface prior care history, current conditions, and likely care pathways. Retrieve a richer clinical history by searching across hundreds of thousands of care providers so teams see the full picture and deliver the right care at the right time.
• Survey Readiness Agent: Monitor for common deficiency risks, flag documentation gaps, and provide templates and checklists that keep teams inspection ready.
• Documentation Agent: Standardize forms and notes, attach the right supporting evidence, and maintain a clean, reviewable record from first touch through discharge.

All agents are built with auditability, role based controls, and safeguards that respect privacy and security requirements. The intent is simple. Reduce the documentation mess, return the focus to patient care, and use the thousands of data points before and after admission to match each person to the right care and the best possible outcome.

Announcing ExaCare AI Summit

ExaCare AI will host the ExaCare AI Summit on April 26, 2026 at The Phoenician in Scottsdale, Arizona. The company will bring together the most innovative CEOs and industry leaders in skilled nursing and long-term care to launch and celebrate the future of AI in the sector. Attendees can expect:

• Keynotes and panels with operators, clinicians, payors, and technologists
• Live demos of ExaCare AI Agents and customer case studies
• Working sessions on admissions acceleration, reimbursement accuracy, and survey readiness

More details and registration will follow.

About ExaCare AI

ExaCare AI is the agentic solution for post-acute admissions. Purpose built for skilled nursing facilities, ExaCare ingests referral data, surfaces critical insights, and standardizes decisioning so teams can say "yes" faster and start care sooner. Learn more at www.exacare.com.

About Insight Partners

Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies that are driving transformative change in their industries. As of June 30, 2025, the firm has over $90B in regulatory assets under management. Insight Partners has invested in more than 875 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Headquartered in New York City, Insight has a global presence with leadership in London, Tel Aviv, and the Bay Area. Insight's mission is to find, fund, and work successfully with visionary executives, providing them with tailored, hands-on software expertise along their growth journey, from their first investment to IPO. For more information on Insight and all its investments, visit insightpartners.com or follow us on X @insightpartners.

About Foundation Capital

Foundation Capital is an early-stage venture firm that partners with founders at "day zero," backing companies across three practice areas: Enterprise AI, Fintech, and Crypto. The firm's approach centers on going early, building deep conviction, and providing high-touch support. The firm is presently making early stage investments out of its Flagship Fund 11, a $600M vehicle announced in March 2025. Since its 1995 founding, dozens of Foundation Capital portfolio companies have gone on to successful IPOs and ICOs. Learn more at foundationcapital.com or follow on X @FoundationCap.

About Bienville Capital

Bienville Capital is an idea-centric investment platform investing across sectors and geographies in both public and private markets. Founded in 2008, Bienville partners with entrepreneurs, investors and families to identify differentiated opportunities that have the potential to drive long-term value creation. The firm's collaborative culture and multi-asset approach enable it to pursue opportunities globally across a range of strategies. Bienville is headquartered in New York, NY and as of June 30, 2025, manages over $4.5B. Learn more at www.bienvillecapital.com.

SOURCE ExaCare AI